Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 EUR | -0.99% |
|
+1.01% | +6.10% |
06-14 | Finland's Biohit Names Chief Technology Officer | MT |
04-15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Business Summary
Number of employees: 46
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Tests, Analysis Systems, and Products
100.0
%
| 11 | 100.0 % | 13 | 100.0 % | +19.40% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe, Other
43.6
%
| 5 | 41.9 % | 6 | 43.6 % | +24.16% |
Asia
34.9
%
| 5 | 43.2 % | 5 | 34.9 % | -3.51% |
Other Countries
17.4
%
| 1 | 10.2 % | 2 | 17.4 % | +103.03% |
North and South America
2.5
%
| 0 | 2.5 % | 0 | 2.5 % | +18.25% |
Finland
1.6
%
| 0 | 2.1 % | 0 | 1.6 % | -10.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jussi Hahtela
CEO | Chief Executive Officer | 51 | 21-06-03 |
Jussi Sorvo
DFI | Director of Finance/CFO | 34 | 20-12-31 |
Panu Hendolin
CTO | Chief Tech/Sci/R&D Officer | 53 | 21-12-31 |
Kalle Härkönen
BRD | Director/Board Member | 56 | 19-12-31 |
Graham Johnson
SAM | Sales & Marketing | - | 11-21 |
General Counsel | 37 | 13-12-31 | |
Ilari Patrakka
PRN | Corporate Officer/Principal | 44 | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 23-06-13 | |
Founder | 81 | 87-12-31 | |
Director/Board Member | 73 | 19-04-23 | |
Kalle Härkönen
BRD | Director/Board Member | 56 | 19-12-31 |
Franco Aiolfi
BRD | Director/Board Member | 77 | 13-04-07 |
Feng Liu
BRD | Director/Board Member | 52 | 18-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 20 | 2,975,500 | 0 | 0 | 42.47 % |
Stock B | 1 | 12,198,093 | 6,444,275 ( 52.83 %) | 0 |
Company contact information
![address Biohit Oyj(BIOBV)](https://cdn.zonebourse.com/static/address/1412435.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.10% | 32.42M | |
+0.10% | 7.29B | |
-10.19% | 4.42B | |
+1.75% | 3.19B | |
+2.94% | 2.04B | |
-31.17% | 1.05B | |
+5.30% | 911M | |
-50.14% | 787M | |
-24.23% | 673M | |
-32.11% | 665M |
- Stock Market
- Equities
- BIOBV Stock
- Company Biohit Oyj